Detalhe da pesquisa
1.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
2.
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.
Am J Hum Genet
; 108(2): 284-294, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421400
3.
Avapritinib for advanced systemic mastocytosis.
Blood
; 140(15): 1667-1673, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877999
4.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130297
5.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
6.
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
Allergy
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651829
7.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
8.
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.
Blood
; 137(15): 2070-2084, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512435
9.
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Allergy
; 78(1): 47-59, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207764
10.
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
Ann Hematol
; 102(8): 2077-2085, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012462
11.
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Am J Hematol
; 98(8): 1286-1306, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283522
12.
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
J Allergy Clin Immunol
; 149(6): 1866-1874, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421448
13.
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022.
J Allergy Clin Immunol
; 149(6): 1855-1865, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430191
14.
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Int J Mol Sci
; 24(20)2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894806
15.
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis.
Blood
; 135(16): 1365-1376, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106312
16.
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases.
Ann Hematol
; 101(8): 1825-1834, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597847
17.
Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis.
Ann Allergy Asthma Immunol
; 128(3): 314-318, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637924
18.
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations.
Br J Haematol
; 194(2): 344-354, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060083
19.
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
J Allergy Clin Immunol
; 146(2): 356-366.e4, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437738
20.
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
J Allergy Clin Immunol
; 146(2): 300-306, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561389